By the last interview, three patients with anti-SRP antibodies had died of severe pulmonary infections and respiratory failure, and lung cancer occurred in an anti-SRP antibody-positive patient 1 year after the diagnosis of IMNM. This evidence concerns the gene UCN2 and lung carcinoma.